<DOC>
	<DOC>NCT02174536</DOC>
	<brief_summary>A prospective double blind randomized study comparing placenta derived decidual stromal cells with placebo for hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. It is hypothesized that the decidual stromal cell therapy will be superior to placebo.</brief_summary>
	<brief_title>A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis</brief_title>
	<detailed_description>Patients with grade 2-4 hemorrhagic cystitis will be randomized to receive either decidual stromal cell therapy at approximately 1x106 cells/kg or placebo on two occasions at weekly intervals. Patients not responsive within 2 weeks will receive decidual stromal cells at approximately 1x106 cells/kg openly.</detailed_description>
	<mesh_term>Cystitis</mesh_term>
	<criteria>Hemorrhagic cystitis grade 24 Receives Misoprostol therapy Patients with urinary urge without macroscopic hematuria or clots</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>